Decreased Activated Dendritic Cells and Monocyte Infiltration, and Altered Immune Microenvironment, in NSCLC Patients With ARID1A, ARID1B, or ARID2 Mutation. The gene discussed is ARID2; the disease is non-small cell lung carcinoma.